ATHA
Athira Pharma Inc
Price:  
0.42 
USD
Volume:  
514,280.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Athira Intrinsic Value

-2,525.97 %
Upside

What is the intrinsic value of Athira?

As of 2025-07-11, the Intrinsic Value of Athira Pharma Inc (ATHA) is -10.21 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.42 USD, the upside of Athira Pharma Inc is -2,525.97%.

Is Athira undervalued or overvalued?

Based on its market price of 0.42 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 2,525.97%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

0.42 USD
Stock Price
-10.21 USD
Intrinsic Value
Intrinsic Value Details

Athira Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -10.21 - -10.21 -10.21 -2,525.97%
P/E (40.12) - (37.99) (39.99) -9597.7%
DDM - Stable (15.56) - (41.98) (28.77) -6933.8%
DDM - Multi (16.51) - (35.25) (22.55) -5456.8%

Athira Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 16.44
Beta 2.37
Outstanding shares (mil) 39.04
Enterprise Value (mil) -9.99
Market risk premium 4.60%
Cost of Equity 10.78%
Cost of Debt 5.00%
WACC 7.23%